Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Aso

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Pharmacology|March 18, 2014
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinicEster Aso, Isidre Ferrer
Expert Opinion on Biological Therapy|May 15, 2013
It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)Ester Aso, Isidre Ferrer
Frontiers in Neuroscience|June 16, 2016
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseEster Aso, Isidro Ferrer
Psychopharmacology|March 22, 2005
Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in miceGraciela N Balerio, Ester Aso, Rafael Maldonado
Biochemical Pharmacology|August 11, 2018
Genetic deletion of CB<sub>1</sub> cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal modelEster Aso, Pol Andrés-Benito, Isidre Ferrer
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine ModelEster Aso, Pol Andrés-Benito, Isidro Ferrer
Psychopharmacology|January 18, 2006
Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in miceGraciela N Balerio, Ester Aso, Rafael Maldonado
Adicciones|April 26, 2022
Impact of the legalisation of recreational cannabis useManuel Isorna, Francisco Pascual, Ester Aso, et al.
Journal of Alzheimer'S Disease : JAD|March 22, 2013
CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 miceEster Aso, Salvador Juvés, Rafael Maldonado, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 10, 2010
Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotypeEster Aso, Andrés Ozaita, Miquel-Àngel Serra, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|March 18, 2014
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinicEster Aso, Isidre Ferrer
Expert Opinion on Biological Therapy|May 15, 2013
It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)Ester Aso, Isidre Ferrer
Frontiers in Neuroscience|June 16, 2016
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseEster Aso, Isidro Ferrer
Psychopharmacology|March 22, 2005
Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in miceGraciela N Balerio, Ester Aso, Rafael Maldonado
Biochemical Pharmacology|August 11, 2018
Genetic deletion of CB<sub>1</sub> cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal modelEster Aso, Pol Andrés-Benito, Isidre Ferrer
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine ModelEster Aso, Pol Andrés-Benito, Isidro Ferrer
Psychopharmacology|January 18, 2006
Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in miceGraciela N Balerio, Ester Aso, Rafael Maldonado
Adicciones|April 26, 2022
Impact of the legalisation of recreational cannabis useManuel Isorna, Francisco Pascual, Ester Aso, et al.
Journal of Alzheimer'S Disease : JAD|March 22, 2013
CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 miceEster Aso, Salvador Juvés, Rafael Maldonado, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 10, 2010
Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotypeEster Aso, Andrés Ozaita, Miquel-Àngel Serra, et al.
Pageof 7